Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.

dc.contributor.author	Giacchetti, Sylvie
dc.contributor.author	Espié, Marc
dc.contributor.author	Chang-Marchand , Yunhua
dc.contributor.author	Arrondeau, Jennifer
dc.contributor.author	Machowiak, Jean
dc.contributor.author	Cuvier, Caroline
dc.contributor.author	Li, Xiao-Mei
dc.contributor.author	ÖZTÜRK, Narin
dc.contributor.author	OKYAR, Alper
dc.contributor.author	Lévi, Francis
dc.date.accessioned	2021-03-05T13:44:32Z
dc.date.available	2021-03-05T13:44:32Z
dc.identifier.citation	Giacchetti S., Li X., ÖZTÜRK N., Cuvier C., Machowiak J., Arrondeau J., Chang-Marchand Y., Espié M., OKYAR A., Lévi F., "Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.", San Antonio Breast Cancer Symposium 2016 (SABCS 2016), Teksas, Amerika Birleşik Devletleri, 6 - 10 Aralık 2016, cilt.77, no.4, ss.10
dc.identifier.other	av_b3b2213d-0560-44a9-8c3d-0afc6db01af0
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/119684
dc.language.iso	eng
dc.subject	Eczacılık
dc.subject	Meslek Bilimleri
dc.subject	Yaşam Bilimleri (LIFE)
dc.subject	Farmakoloji ve Toksikoloji
dc.subject	Sağlık Bilimleri
dc.title	Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	77
dc.contributor.firstauthorID	620604

Files in this item

Files	Size	Format	View
There are no files associated with this item.